CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Salt Lake City, Utah, United States and 205 other locations
in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung cancer...
Phase 3
Salt Lake City, Utah, United States and 139 other locations
and safety of osimertinib following chemoradiation in patients with stage III unresectable Epidermal Growth Factor Receptor Mutation Positive non...
Phase 3
Salt Lake City, Utah, United States and 117 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Ogden, Utah, United States and 268 other locations
in previously untreated patients with locally advanced or metastatic non-squamous Non-Small Cell Lung Ca...
Phase 3
Salt Lake City, Utah, United States and 197 other locations
with osimertinib in subjects with locally advanced or metastatic non-small cell lung cancer (NSCLC)....
Phase 1, Phase 2
Salt Lake City, Utah, United States and 30 other locations
This study has 2 parts. The first part was open to adults with advanced non-small cell lung cancer. The ...
Phase 1
Salt Lake City, Utah, United States and 42 other locations
To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer...
Phase 3
Ogden, Utah, United States of America and 119 other locations
pembrolizumab alone in participants with advanced or metastatic non-small cell lung cancer (NSCLC)....
Phase 3
Salt Lake City, Utah, United States and 229 other locations
versus standard of care chemotherapy for the treatment of non-small cell lung cancer that is stage IV or...
Phase 3
Salt Lake City, Utah, United States and 566 other locations
Clinical trials
Research sites
Resources
Legal